United States · FDA National Drug Code directory
GAVISCON
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0135-0095_4aba2043-4dde-0c18-e063-6294a90a5fcf
- Product NDC
- 0135-0095
- Form
- LIQUID
- Composition / generic term
- aluminum hydroxide and magnesium carbonate
- Labeler
- Haleon US Holdings LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20110114
- Source listing expiry
- 20271231
Source-listed ingredients
- ALUMINUM HYDROXIDE — 254 mg/5mL
- MAGNESIUM CARBONATE — 237.5 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 355 mL in 1 BOTTLE (0135-0095-41) · 0135-0095-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →